Academic panel to define best practices for outpatient stem cell procedure

Written by Alan Condon | August 09, 2019 | Print  |

A group of orthobiologics experts established a Delphi panel process to set treatment standards for an outpatient stem cell procedure known as bone marrow concentrate.

Three things to know:

1. The panel incorporates specialists from orthopedic surgery, interventional spine, sports medicine and pain management among others.

2. They will break down practice items such as informed consent, the use of image guidance and treatment registry, publishing results and advertising.

3. The panel features specialists from Mayo Clinic in Rochester, Minn.; Hospital for Special Surgery in New York City; Stanford (Calif.) University; and Harvard University in Boston, among others. Christopher Centeno, MD, chief medical officer of Regenexx, organized the panel.

More articles on biologics:
Why Dr. Dominic Thomas Kleinhenz joined University Orthopedics and the biggest obstacle in spine
Dr. Stephen Hochschuler: Future trends in spine – telemedicine, robotics, AI & more
Dr. Christopher Kager: The standout spine procedure in his career, future of biologics & more



© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months